Travere Therapeutics, Inc.

TVTX · Healthcare

$65.71

Capitalizzazione: 6.19B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Travere Therapeutics, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

Insider Monkey4 set 2026, 10:44

Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book

Investor's Business Daily24 ago 2026, 16:56

TGTX Stock Outperforms 95% of Stocks. Here's Why.

Investor's Business Daily21 ago 2026, 17:09

IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'

Investor's Business Daily21 ago 2026, 16:09

Three Biotech Stocks Stick Out With Their Stellar Charts

MarketBeat18 ago 2026, 10:01

Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline